TONY MAKHLOUF MD NPI 1992932214

NPI Information

  • NPI: 1992932214
  • Provider Name: TONY MAKHLOUF, MD
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 143 PARROT LN
    SIMI VALLEY, CA
    ZIP 93065
  • Phone: (805) 842-1793

Map and Directions

Get Directions

NPI Details

Tony Makhlouf, MD is a rheumatology internal medicine in Simi Valley, CA with 22 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Tony Makhlouf, MD NPI is 1992932214. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

143 PARROT LN
SIMI VALLEY, CA
ZIP 93065-151
Phone: (805) 842-1793
Fax: (805) 842-1793

The NPI 1992932214 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg (HCPCS:J7328)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, rituximab, 10 mg (HCPCS:J9312)
  • Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg (HCPCS:J7320)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
  • Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic (HCPCS:G2012)
  • Aspiration and/or injection of fluid from small joint (HCPCS:20600)
  • Hospital discharge day management, more than 30 minutes (HCPCS:99239)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)

The enumeration date for this NPI number is 6/12/2009 and was last updated on 6/28/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1208M00000XHospitalistA127473CALIFORNIANo
2207RR0500XInternal MedicineRheumatologyA127473CALIFORNIAYes
3207R00000XInternal MedicineBP1-0034891TEXASNo

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.